ARHS vs LLY · P/E 14, rev $699.2M vs P/E 39, rev $22.97B
Arhaus Inc (ARHS) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Arhaus Inc (ARHS) is a specialty retail company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported ARHS revenue for 2026-06-30 was $699.2M. Net income was $41.9M. ARHS currently screens at market cap $924.3M and trailing P/E 13.9.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ARHS currently screens at market cap $924.3M and trailing P/E 13.9. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ARHS and LLY stock pages for the full models.
Not investment advice.